Waldemar Radziszewski

789 total citations
30 papers, 622 citations indexed

About

Waldemar Radziszewski is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Waldemar Radziszewski has authored 30 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 10 papers in Cardiology and Cardiovascular Medicine and 7 papers in Immunology. Recurrent topics in Waldemar Radziszewski's work include Nitric Oxide and Endothelin Effects (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Waldemar Radziszewski is often cited by papers focused on Nitric Oxide and Endothelin Effects (10 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Waldemar Radziszewski collaborates with scholars based in United States, Poland and United Kingdom. Waldemar Radziszewski's co-authors include Artur Zembowicz, Ryszard J. Gryglewski, John R. Vane, Małgorzata Setkowicz, Andrzej Szczeklik, Lucyna Mastalerz, Richard Hatchett, Daniela Salvemini, Ryszard Korbut and Xie L. Xu and has published in prestigious journals such as Gastroenterology, Biochemical and Biophysical Research Communications and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Waldemar Radziszewski

29 papers receiving 601 citations

Peers

Waldemar Radziszewski

PHYSI

RHEUM

IMMUN

PHARM

Adrian Devine United Kingdom

Armel Fradin France

Markus Hildner Germany

Hanna E. Agardh Sweden

Leighton R. James United States

S Stürzebecher United States

Hiroki Saito Japan

Alessio Metere Italy

P. V. Halushka United States

C.G. Vinagre Brazil

Adrian Devine United Kingdom

Waldemar Radziszewski

138 ×0.8

PHYSI

98 ×0.7

RHEUM

109 ×0.8

IMMUN

23 ×0.2

PHARM

179 ×1.6

Citations per year, relative to Waldemar Radziszewski Waldemar Radziszewski (= 1×) peers Adrian Devine

Countries citing papers authored by Waldemar Radziszewski

Since Specialization

Citations

This map shows the geographic impact of Waldemar Radziszewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Waldemar Radziszewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Waldemar Radziszewski more than expected).

Fields of papers citing papers by Waldemar Radziszewski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Waldemar Radziszewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Waldemar Radziszewski. The network helps show where Waldemar Radziszewski may publish in the future.

Co-authorship network of co-authors of Waldemar Radziszewski

This figure shows the co-authorship network connecting the top 25 collaborators of Waldemar Radziszewski. A scholar is included among the top collaborators of Waldemar Radziszewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Waldemar Radziszewski. Waldemar Radziszewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jin, Ran, et al.. (2023). Real-World Experience of Adalimumab Biosimilar (ABP 501) Use in Patients with Inflammatory Bowel Disease in Europe. Advances in Therapy. 41(1). 331–348. 6 indexed citations

Smolen, Josef S, Sandeep K. Agarwal, Е. П. Иливанова, et al.. (2017). A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate. Annals of the Rheumatic Diseases. 76(5). 831–839. 113 indexed citations

Thurmond, Robin L., Andrew Greenspan, Waldemar Radziszewski, et al.. (2016). Toreforant, A Histamine H4 Receptor Antagonist, in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results of 2 Phase II Studies. The Journal of Rheumatology. 43(9). 1637–1642. 16 indexed citations

Gheorghiade, Mihai, Stephen J. Greene, Piotr Ponikowski, et al.. (2013). Haemodynamic Effects, Safety, and Pharmacokinetics of Human Stresscopin in Heart Failure with Reduced Ejection Fraction. European Journal of Heart Failure. 15(6). 679–689. 29 indexed citations

Kam, Pieter‐Jan de, Wen‐Lin Luo, Larissa Wenning, et al.. (2013). The effects of laropiprant on the antiplatelet activity of co-administered clopidogrel and aspirin. Platelets. 25(7). 480–487. 3 indexed citations

Dallob, Aimée, Wen‐Lin Luo, Amy O. Johnson‐Levonas, et al.. (2011). The effects of laropiprant, a selective prostaglandin D₂receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin. Platelets. 22(7). 495–503. 8 indexed citations

Chen, Fabian, Edward A. O’Neill, Chan Beals, et al.. (2011). A randomized clinical trial comparing point-of-care platelet function assays and bleeding time in healthy subjects treated with aspirin or clopidogrel. Platelets. 23(4). 249–258. 16 indexed citations

Radziszewski, Waldemar, Eseng Lai, Mark Stroh, et al.. (2010). A Single Supratherapeutic Dose of Rolofylline Does Not Prolong the QTcF Interval in Healthy Volunteers. American Journal of Therapeutics. 17(1). 8–16. 1 indexed citations

Stroh, Mark, Victor Dishy, Waldemar Radziszewski, et al.. (2010). The Effects of Multiple Doses of Rolofylline on the Single-Dose Pharmacokinetics of Midazolam in Healthy Subjects. American Journal of Therapeutics. 17(1). 53–60. 3 indexed citations

10.

Lai, Eseng, M. Gerard Waters, James R. Tata, et al.. (2008). Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humans. Journal of clinical lipidology. 2(5). 375–383. 41 indexed citations

11.

Zembowicz, Artur, Lucyna Mastalerz, Małgorzata Setkowicz, Waldemar Radziszewski, & Andrzej Szczeklik. (2004). Histological spectrum of cutaneous reactions to aspirin in chronic idiopathic urticaria. Journal of Cutaneous Pathology. 31(4). 323–329. 7 indexed citations

12.

Zembowicz, Artur, Lucyna Mastalerz, Małgorzata Setkowicz, Waldemar Radziszewski, & Andrzej Szczeklik. (2003). Safety of Cyclooxygenase 2 Inhibitors and Increased Leukotriene Synthesis in Chronic Idiopathic Urticaria With Sensitivity to Nonsteroidal Anti-inflammatory Drugs. Archives of Dermatology. 139(12). 1577–82. 85 indexed citations

13.

Patre, Pier Luigi Di, et al.. (2000). A Meningioma-Mimicking Tumor Caused by Mycobacterium avium Complex in an Immunocompromised Patient. The American Journal of Surgical Pathology. 24(1). 136–136. 24 indexed citations

14.

Shao, Zhi‐Ming, Waldemar Radziszewski, & Sanford H. Barsky. (2000). Tamoxifen enhances myoepithelial cell suppression of human breast carcinoma progression in vitro by two different effector mechanisms. Cancer Letters. 157(2). 133–144. 30 indexed citations

15.

Radziszewski, Waldemar, Mani Chopra, Artur Zembowicz, et al.. (1995). Nitric oxide donors induce extrusion of cyclic GMP from isolated human blood platelets by a mechanism which may be modulated by prostaglandins. International Journal of Cardiology. 51(3). 211–220. 14 indexed citations

16.

Surdacki, Andrzej, et al.. (1994). Plasma ANP and Cyclic GMP Levels Versus Left Ventricular Performance at Different AV Delays in AV Sequential Pacing. Pacing and Clinical Electrophysiology. 17(4). 627–636. 6 indexed citations

17.

Radziszewski, Waldemar, Andrzej Surdacki, Pauli Vuorinen, et al.. (1993). Plasma ANP and cyclic GMP after physical exercise in patients with mitral valve disease and in healthy subjects. International Journal of Cardiology. 40(3). 203–209. 3 indexed citations

18.

Zembowicz, Artur, Richard Hatchett, Waldemar Radziszewski, & Ryszard J. Gryglewski. (1993). Inhibition of endothelial nitric oxide synthase by ebselen. Prevention by thiols suggests the inactivation by ebselen of a critical thiol essential for the catalytic activity of nitric oxide synthase.. Journal of Pharmacology and Experimental Therapeutics. 267(3). 1112–1118. 72 indexed citations

19.

Zembowicz, Artur, Stefan Chłopicki, Waldemar Radziszewski, John R. Vane, & R.J. Gryglewski. (1992). NG-hydroxy-l-arginine and hydroxyguanidine potentiate the biological activity of endothelium-derived relaxing factor released from the rabbit aorta. Biochemical and Biophysical Research Communications. 189(2). 711–716. 10 indexed citations

20.

Salvemini, Daniela, Waldemar Radziszewski, Ryszard Korbut, & John R. Vane. (1990). The use of oxyhaemoglobin to explore the events underlying inhibition of platelet aggregation induced by NO or NO‐donors. British Journal of Pharmacology. 101(4). 991–995. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact